vimarsana.com

Latest Breaking News On - முதலீடு இணை லிமிடெட் - Page 1 : vimarsana.com

TRADING UPDATES: Sareum raises GBP1 million; Marlowe buys Core Stream

TRADING UPDATES: Sareum raises GBP1 million; Marlowe buys Core Stream
lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.

Algolux Closes $18 4 Million Series B Round for Robust Computer Vision

Algolux Closes $18 4 Million Series B Round for Robust Computer Vision
prnewswire.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.co.uk Daily Mail and Mail on Sunday newspapers.

Chinese lanterns shed light on China | Breaking Travel News

Ringing out the Old Year with the sounds of drums and gongs, China is brightly lit in the light of festive lanterns. In Xi’an, the ancient capital of thirteen dynasties with a long history, tens of thousands of festive lanterns, along with the charms of the ancient city, add radiance and beauty to each other and represent the brilliant prosperity of the Tang Dynasty. On February 8, the 2018 Xi’an City Wall Lighting Ceremony of the OCT Zigong Lantern Show was held grandly at the Xi’an City Wall. Huang Xiaohua, Deputy Secretary of the People’s Government of Xi’an City; Tan Bao, the director of the NPC Standing Committee of Zigong City; Chen Zhangming, the vice mayor of the People’s Government of Zigong City; Mao Yixiang, the Director of the News Center of State-owned Assets Supervision and Administration Commission (SASAC); Li Tiejun, Deputy Director of Qujiang New District Administrative Committee; He Ming, Deputy General Manager of the OCT Western Investment Co., Ltd.; Qi

GeneQuantum Raises Hundreds of Millions RMB in Series C Funding

GeneQuantum Raises Hundreds of Millions RMB in Series C Funding News provided by Share this article Share this article SUZHOU, China, May 18, 2021 /PRNewswire/ GeneQuantum Healthcare (Suzhou) Co., Ltd. (hereinafter GeneQuantum ) announced the completion of Series C fund raising of several hundreds of millions RMB. This series of fund raising is led by China Life Private Equity Investment, jointly by PICC Capital Equity Investment, Sunshine Guojian and Suzhou Wuzhong Biomedicine Industrial Park Investment. The current fund raising will provide a solid financial foundation to GeneQuantum for its global clinical development and pipeline expansion of next generation site-specific bioconjugates. Since its establishment, GeneQuantum has focused on the development of innovative bioconjugate drugs represented by Antibody-Drug-Conjugate (ADC). We possess highly differentiated ADC technology platforms, including enzyme catalyzed site-specific conjugation technology, innovative li

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.